|
|
Clinically Proven & Approved Dry Macular Degeneration TreatmentAge-related Macular Degeneration (AMD) is the gradual deterioration of the macula, the central part of the retina responsible for sharp vision. It is the leading cause of blindness in individuals over 55 affecting 2.5 million Canadians. It usually has no symptoms in the early stages but as it progresses it causes blurriness or distortion, difficulty seeing in low light and poor colour perception. AMD can reduce your quality of life making everyday activities like reading driving and recognizing faces challenging. I have been treating patients with AMD since I first started practice. Initially I had no treatments to offer other than education about why my patient was going to lose their central vision in the next 3 to 5 years. Eventually vitamin therapy was developed to slow the progress of AMD and that changed the prognosis to losing vision over 10 years. When injections were developed for wet AMD more vision was saved but it only helps 10% of patients with AMD. Now I can offer a therapy that actually improves the vision of my patients with AMD. I am grateful to see that MacuMira treatments are improving the quality of life for my patients. What is MacuMira?MacuMira is a major breakthrough in managing dry AMD. It offers new hope for those looking to protect and preserve their vision. We are excited to offer Canada’s first clinically proven, approved by Health Canada treatment for dry AMD. This safe, non-invasive therapy restores vision loss due to dry AMD and improves your quality of life. MacuMira is particularly suited for individuals in the early to intermediate stages of dry AMD. It may also be helpful for those who experience mild to moderate vision loss and are looking for ways to preserve their remaining sight. How does MacuMira work?MacuMira uses gentle, painless microcurrent therapy applied over closed eyelids to stimulate retinal pigment epithelium (RPE) cells generating more energy and rejuvenating the macula to improve your visual health. MacuMira is not a cure for AMD. It is a management tool that can help improve visual function including Contrast Sensitivity and Visual Acuity, and slow the progression of the disease. What to Expect During Your MacuMira TreatmentThe treatment is comfortable and noninvasive and involves no injections or medications. Your treatments start with four sessions over 10 days, each lasting about 45 minutes. During treatment:
To maintain the benefits of the treatment, you’ll typically have follow-up sessions every 2.5 to 3 months. 
Benefits of MacuMira?MacuMira offers a pain-free, easy, and effective solution for managing dry age-related macular degeneration. Clinical studies confirm that MacuMira significantly enhances vision and quality of life in just 10 days. Results will vary depending on the severity of your AMD but this revolutionary therapy marks a major leap in patient care, delivering rapid and effective results for preserving visual health. Improved Visual AcuityAfter treatment many patients have noticeable improvements in their ability to see detail. This makes tasks like reading, and recognizing faces easier. Slowing Disease ProgressionWhile MacuMira is not a cure for AMD, it may help to slow the progression of the disease as it treats some of the underlying causes of vision loss in AMD patients. Call SPECTRUM Optometry at 604-536-2050 to schedule a consultation to see if you're a candidate for our MacuMira treatment.Sehic, Amer et al. - Electrical Stimulation as a Means for Improving Vision More Information available at https://macumira.com/. |
